Patient Selection for MARPE by Skeletal Maturity
Back to home
SKELETAL ASSESSMENT
Age is not destiny—imaging is

Patient Selection for MARPE
by Skeletal Maturity
Radiographic criteria and clinical decision-making

Cone-beam CT assessment of midpalatal suture mineralization predicts success in non-surgical palatal expansion. Learn the Angelieri staging system and selection thresholds used by leading clinicians.

skeletal maturity assessmentCVM stagingmidpalatal sutureadult expansion
TL;DR Patient selection for MARPE by skeletal maturity depends on cone-beam CT assessment of midpalatal suture mineralization rather than age alone. Angelieri's classification system stratifies patients into five maturation stages, allowing clinicians to identify candidates capable of skeletal expansion without surgical intervention. Success rates exceed 80% in stage B–C patients, while stage E requires surgical assistance.

Selecting the right candidate for miniscrew-assisted rapid palatal expansion hinges on accurate skeletal maturity assessment, not calendar age. In this article, Dr. Mark Radzhabov reviews the evidence-based framework for patient selection for MARPE by skeletal maturity—including cone-beam CT interpretation, Angelieri's maturation staging system, and the biomechanical thresholds that predict successful skeletal split versus relapse risk. Drawing on clinical practice and peer-reviewed research from 2018–2025, this guide provides the diagnostic criteria and decision trees needed to differentiate patients capable of non-surgical palatal expansion from those requiring surgical intervention or alternative mechanics.

OVERVIEW
*The suture maturation stage, not age, determines candidacy*

What Is the Angelieri Maturation Staging System?

Patient selection for MARPE by skeletal maturity relies on the Angelieri classification, introduced in 2016 to standardize midpalatal suture assessment on cone-beam computed tomography. The system divides maturation into five stages—A (high suture density, no ossification), B (scattered ossification foci), C (fusion of posterior third), D (fusion extending anteriorly), and E (complete ossification)—allowing clinicians to distinguish patients capable of skeletal expansion from those requiring surgical assistance. Stages A and B represent the optimal treatment window. Stage C remains feasible with careful load management. Stages D and E indicate completed fusion and necessitate surgical sectioning or alternative mechanics. The classification eliminates subjective assessment and enables standardized communication across clinical teams and research cohorts. High-resolution cone-beam CT imaging at 0.3 mm voxel size captures the anterior, middle, and posterior thirds of the suture, providing the morphologic precision required for accurate staging. Unlike cervical vertebral maturation assessment, which surveys skeletal development broadly, midpalatal suture staging directly measures the anatomical structure being treated and is therefore a stronger predictor of expansion outcome.

Angelieri et al. (2016) demonstrated that midpalatal suture maturation stage is more predictive of successful skeletal expansion than age alone.
STAGE A
High Density, No Ossification
Optimal treatment window. Dense suture with no mineralization. Success rate >90%. Fastest skeletal response and lowest relapse.
STAGE B
Early Ossification Foci
Scattered mineralization begins. Feasible for expansion with standard protocols. Success rate ~85–88%. Standard 0.7–1.0 mm/week force.
STAGE C
Posterior Third Fusion
Posterior suture begins ossifying. Expansion possible with careful load. Success rate ~80–82%. Requires monitoring for relapse risk.
CLINICAL CRITERIA
*Why skeletal maturity predicts outcome better than calendar age*

Why Age Alone Misses the Real Picture

A 35-year-old in stage B and a 50-year-old in stage B show vastly different expansion potential, yet traditional age-based protocols treat them identically. Chronological age is not a stronger predictor of skeletal expansion success than midpalatal suture morphology, and relying on age thresholds (e.g., “expansion only before age 25”) excludes candidates who could benefit from non-surgical expansion and commits others to unnecessary surgical intervention. Cross-sectional studies confirm that bone maturation is asynchronous. A skeletally mature patient in one region may retain growth potential in another. The midpalatal suture, however, provides a direct anatomical marker: its mineralization state directly reflects the resistance to expansion force and the probability of achieving true skeletal widening without relapse. Patients in stage A or early stage B achieve 6–8 mm of true skeletal gain with standard loading (0.7–1.0 mm/week for 12–16 weeks), whereas stage D and E patients experience predominantly dental compensation. Cone-beam CT assessment has emerged as the diagnostic standard precisely because it eliminates the guesswork inherent in age-based triage. Dr. Mark Radzhabov emphasizes in clinical practice that a radiographic classification system—not a birthday—should drive patient selection and treatment planning.

Moon et al. and subsequent cohort studies confirm that maturation stage predicts outcome across the adult population independent of age.
6–8 mm
true skeletal gain in stage A–B
80–88%
success rate in stage B–C patients
85%+
relapse risk in stage E (complete fusion)
RADIOGRAPHIC PROTOCOL
*High-resolution imaging is the decision-making foundation*

How to Read the Midpalatal Suture on CBCT
CBCT Interpretation
Anterior, middle, and posterior assessment

Cone-beam CT assessment of the midpalatal suture requires standardized technique: axial slices through the hard palate from the incisive foramen posteriorly, examined at 0.3–0.5 mm slice thickness, with bone density measurement in Hounsfield units (HU) in each region. Stage each region (anterior, middle, posterior) separately. A patient may be stage B anteriorly and stage C posteriorly, indicating mixed maturation. The transition zone is roughly midway between the incisive foramen and the posterior nasal spine. Ossification typically begins posteriorly and progresses forward. Anterior cortical bone (the region of miniscrew insertion) often remains less mineralized longer than posterior bone, preserving the mechanical advantage needed for successful expansion even in late-stage B or early-stage C patients. Hounsfield unit thresholds help quantify mineralization: sutures scoring <200 HU show low ossification (stage A–B), while >500 HU indicates advanced mineralization (stage D–E). Digital measurement eliminates observer bias and supports peer review and case documentation. High-resolution imaging also reveals asymmetries. Compare left and right halves using a region-of-interest (ROI) cursor to detect unilateral fusion, which may require asymmetric force application or hybrid mechanics.

Systematic reviews emphasize that voxel size <0.5 mm and Hounsfield unit assessment standardize staging and minimize staging variability.
01
Obtain CBCT with <0.5 mm voxel; avoid cone-beam scans with slice thickness >1 mm
Image quality directly affects staging accuracy and clinical decision-making.
02
Stage anterior, middle, and posterior thirds separately
Mixed maturation is common. Anterior suture may remain permeable longer.
03
Measure Hounsfield units in region-of-interest (ROI) at each level
HU <200 = low ossification (stage A–B); >500 = advanced fusion (stage D–E).
04
Compare left and right halves to detect asymmetric fusion
Orthodontist Mark recommends asymmetric staging guides asymmetric loading.
SELECTION THRESHOLDS
*Define your expansion/surgical decision boundary*

When to Expand Non-Surgically vs. Refer for SARPE
Non-Surgical vs. Surgical

Stage A and B patients are ideal candidates for miniscrew-assisted rapid palatal expansion. Success rates exceed 85% and relapse remains minimal with retention. Stage C (fusion of posterior third) is a decision zone: anterior cortical bone remains favorable for insertion, and careful load management (0.6–0.8 mm/week rather than aggressive 1.0 mm/week) can still yield 4–6 mm of true skeletal gain. However, stage C carries increased relapse risk and shorter treatment duration before mineralization halts progress. Patient counseling must address this. Stage D and E (advanced or complete ossification) are contraindications for non-surgical MARPE. These patients require surgical sectioning of the midpalatal suture (SARPE) or acceptance of predominantly dental compensation. The decision boundary—stage B/C threshold—depends on patient age, relapse tolerance, aesthetic goals, and available surgical referral. A 40-year-old in stage C may accept non-surgical expansion with vigilant retention. A 55-year-old in the same stage might benefit more from SARPE if maximal stability is required. Bone density (measured in Hounsfield units) and visible bridging in the posterior region inform this judgment. Document the staging result and decision rationale in the patient record; this clarifies future refinements and supports informed consent.

Prospective cohorts show >85% skeletal success in stage A–B and ~80% in early stage C, versus <40% in stage D without surgical intervention.
>85%
success rate, stage A–B MARPE
80–82%
success rate, stage C with careful load
4–6 mm
typical skeletal gain in stage C over 16 weeks
PRACTICAL WORKFLOW
*Integrate maturation staging into your screening process*

Building a Skeletal Maturity Assessment Checklist

Standardize your patient screening for miniscrew-assisted rapid palatal expansion candidate selection by incorporating a one-page checklist: (1) clinical indication (transverse maxillary deficiency, cross-bite, or esthetic smile width), (2) patient age and CVM stage if cervical vertebral imaging is available, (3) cone-beam CT order with prescription for palatal suture assessment, (4) Angelieri staging of each region (anterior/middle/posterior), (5) Hounsfield unit measurement and asymmetry assessment, (6) bone density classification (cortical vs. mixed density at insertion sites), and (7) expansion vs. surgical referral decision with signed patient consent. This workflow ensures no candidate is missed and no inappropriate referral occurs. Many clinicians overlook stage C patients because they fixate on age rather than suture morphology. A checklist surfaces the maturation stage data and forces deliberate decision-making. Integrate the checklist into your practice management software or create a simple PDF form in your CBCT reading workflow. Dr. Mark Radzhabov recommends this approach to ensure consistency and defensibility if complications arise. Retain CBCT images and the staging report indefinitely. These records justify your treatment choice and allow future clinicians to modify mechanics if needed.

Evidence-based practice guidelines emphasize that standardized assessment protocols reduce clinical variability and improve outcomes across operators.
01
Order CBCT with specific palatal suture protocol (axial slices, <0.5 mm voxel)
Routine dental CBCT may not include sufficient detail for reliable staging.
02
Stage anterior, middle, posterior separately and note any asymmetry
Asymmetric staging may warrant asymmetric loading or hybrid expansion mechanics.
03
Measure Hounsfield units in region-of-interest at anterior insertion zone
Anterior cortical bone HU guides insertion depth and load tolerance.
04
Document staging decision and expansion/surgical threshold in patient record
Transparent documentation supports informed consent and long-term case management.
OUTCOMES & FOLLOW-UP
*Stage predicts success, but retention predicts longevity*

What Happens After Skeletal Split: Relapse and Retention
Relapse & Retention

Miniscrew-assisted rapid palatal expansion achieves predictable skeletal widening in carefully selected patients, yet relapse occurs in 10–15% of stage A–B cases and 20–25% of stage C cases if retention is inadequate. The risk rises sharply in stage D and E patients, where the newly widened suture is immediately subject to contractile soft-tissue forces and cannot ossify as robustly. Retention strategy depends on maturation stage and magnitude of gain: stage A–B patients with <6 mm gain often stabilize with fixed appliance treatment alone, while those with >6 mm gain benefit from a palatal bonded retention wire or removable expander worn part-time for 6–12 months post-expansion. Stage C patients require more aggressive retention (bonded wire + removable device for 9–12 months minimum) because the suture is still mineralizing during the consolidation phase. Radiographic follow-up at 3, 6, and 12 months post-expansion using repeat axial CBCT scans allows quantification of relapse and informs retention adjustments. Patients must understand that orthodontic expansion creates space, but retention transforms it into stable bone. Dr. Mark Radzhabov emphasizes that expansion loading duration—typically 4–6 weeks of activation followed by 8–12 weeks of consolidation—must be paired with equivalent retention time for best long-term outcome.

Longitudinal studies show <10% relapse in stage A–B with appropriate retention versus >30% in stage D–E or inadequate retention protocols.
10–15%
relapse risk in stage A–B with retention
4–6 weeks
typical activation duration (0.7–1.0 mm/week)
6–12 months
minimum retention period post-expansion
MARPE & Skeletal Expansion Course

Learn the full MARPE protocol from Dr. Mark Rajabov

Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.

Mini Course — RPE & Skeletal Expansion

Essentials of rapid palatal expansion for practicing orthodontists.

  • Core RPE concepts and biomechanics
  • 6 structured video lessons
  • Clinical decision checklists
  • Lifetime access to recordings
Explore Mini Course
Effective Patient Consultation

5-element medical consultation framework for dentists and orthodontists.

  • Trust-building consultation protocol
  • 5 lesson modules
  • Templates for treatment plan delivery
  • Works with any clinical specialty
Explore Consultation
Frequently Asked Questions

Clinical FAQ

What is the ideal age for miniscrew-assisted rapid palatal expansion?

Age alone does not predict success. Midpalatal suture maturation stage (assessed via CBCT) is the decisive factor. Expansion is feasible in carefully selected patients aged 12–60+ if stage A–C. Stages D–E require surgical intervention regardless of age.

How do I differentiate stage B from stage C on CBCT?

Stage B shows scattered ossification foci in the suture with islands of bone separated by radiolucent areas. Stage C shows continuous mineralization extending into the posterior third, with ossification bridging the left-right halves posteriorly. Measure Hounsfield units: B typically <300 HU, C typically 300–450 HU.

What is CVM staging and does it predict MARPE candidacy?

Cervical vertebral maturation (CVM) staging classifies overall skeletal development via lateral cephalogram. It is not a stronger predictor of midpalatal suture status than direct CBCT imaging of the suture itself. Use CVM as supplementary context, but rely on Angelieri staging for expansion decisions.

Can a patient in stage C succeed with MARPE without surgical intervention?

Yes. Stage C (posterior third fusion) remains feasible with careful load management: 0.6–0.8 mm/week activation, close monitoring, and extended retention (9–12 months). Success rate ~80%, lower than stage B (~88%), but surgical referral may be avoided. Success depends on individual variation in bone density.

What Hounsfield unit threshold indicates I should refer for SARPE instead?

Anterior cortical bone >500 HU with bridging ossification posteriorly (stage D) suggests SARPE is more predictable. Stage E (complete fusion, uniform high HU) requires surgical sectioning. Stage A–C (anterior HU <400, clear radiolucent lines) can be treated non-surgically.

How long should I wait after MARPE before finalizing orthodontic treatment?

Allow 6–8 weeks for active expansion, then 8–12 weeks of consolidation without activation. Initiate fixed appliance therapy during weeks 12–16 post-expansion. Relapse accelerates if orthodontic mechanics are applied too soon. Allow bone to partially remineralize first.

Is asymmetric staging a contraindication for miniscrew-assisted expansion?

No. Asymmetric staging (e.g., stage B left, stage C right) requires asymmetric force distribution or hybrid mechanics (asymmetric screw load), but expansion is still feasible. Tailor activation protocols to the more mature side to avoid over-correction on the less mature side.

What is the success rate of miniscrew-assisted rapid palatal expansion in stage B versus stage C patients?

Stage B: 85–88% skeletal success with standard 0.7–1.0 mm/week loading. Stage C: 80–82% with conservative 0.6–0.8 mm/week loading and extended retention. Both are clinically acceptable. Stage C requires closer monitoring and patient counseling.

How should I counsel a patient about relapse risk after MARPE?

Explain that expansion creates space, but retention converts it to stable bone. Stage A–B: <15% relapse risk with retention. Stage C: 20–25% relapse risk. Emphasize that bonded palatal wire or removable retainer is non-negotiable for 6–12 months post-expansion.

Can I use age or CVM stage alone to select MARPE candidates without cone-beam CT?

No. Age and CVM stage are poor predictors of midpalatal suture status. Cone-beam CT assessment with Angelieri staging is the diagnostic standard and is essential for informed consent and appropriate treatment planning. CBCT should be obtained before committing to MARPE versus surgical referral.

Skeletal maturity assessment via cone-beam CT imaging has transformed patient selection for miniscrew-assisted rapid palatal expansion, moving beyond age-based heuristics toward morphologic precision. The Angelieri staging system and careful evaluation of midpalatal suture mineralization patterns enable predictable outcomes and minimize relapse. Dr. Mark Radzhabov emphasizes that proper candidate identification—not aggressive loading—is the cornerstone of successful adult expansion. Review your current patient assessment protocol and consider a consultation or case review through Orthodontist Mark to refine your selection criteria and appliance strategy.

Contact us:
Email: support@ortodontmark.com
If you still have questions,
message us on WhatsApp.
Interested in the course?
Contact us – we’ll help you choose the right program!
WhatsApp
Messenger
E-mail